$VTRS

The 'Improving Access to Care for Rural Veterans Act' (S3033) advances, indicating increased federal spending on rural veteran healthcare. This bill directly benefits pharmaceutical companies, medical device manufacturers, and healthcare providers with rural presences, as it expands access to care and associated services.

The Advancing Education on Biosimilars Act of 2021 increases awareness and adoption of biosimilar drugs, directly benefiting biosimilar manufacturers and increasing competition for branded biologic drug companies. This legislation expands the market for biosimilars and drives down healthcare costs.

The 'Skinny Labels, Big Savings Act' directly targets brand-name pharmaceutical companies by limiting their ability to block generic competition. This legislation will reduce drug prices and significantly decrease revenue for innovator drug manufacturers, while benefiting generic drug producers.